Cargando…

Angiopoietin-Like Protein 3 (ANGPTL3) Modulates Lipoprotein Metabolism and Dyslipidemia

Dyslipidemia is characterized by increasing plasma levels of low-density lipoprotein-cholesterol (LDL-C), triglycerides (TGs) and TG-rich lipoproteins (TGRLs) and is a major risk factor for the development of atherosclerotic cardiovascular disorders (ASCVDs). It is important to understand the metabo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Pei-Yi, Gao, Wan-Yun, Liou, Je-Wen, Lin, Ching-Yen, Wu, Ming-Jiuan, Yen, Jui-Hung
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8304944/ https://www.ncbi.nlm.nih.gov/pubmed/34298929 http://dx.doi.org/10.3390/ijms22147310

Ejemplares similares

The Citrus Flavonoid Nobiletin Downregulates Angiopoietin-like Protein 3 (ANGPTL3) Expression and Exhibits Lipid-Modulating Effects in Hepatic Cells and Adult Zebrafish Models
por: Lin, Ching-Yen, et al.
Publicado: (2022)

The Lipid-Modulating Effect of Tangeretin on the Inhibition of Angiopoietin-like 3 (ANGPTL3) Gene Expression through Regulation of LXRα Activation in Hepatic Cells
por: Chen, Pei-Yi, et al.
Publicado: (2021)

Angiopoietin-like protein 3 (ANGPTL3) deficiency and familial combined hypolipidemia
por: Tarugi, Patrizia, et al.
Publicado: (2019)

Angiopoietin-Like Protein 3 (ANGPTL3) Inhibitors in the Management of Refractory Hypercholesterolemia
por: Kosmas, Constantine E, et al.
Publicado: (2022)

Angiopoietin-Like 3 (ANGPTL3) and Atherosclerosis: Lipid and Non-Lipid Related Effects
por: Lupo, Maria Giovanna, et al.
Publicado: (2018)

Angiopoietin-like protein 8 differentially regulates ANGPTL3 and ANGPTL4 during postprandial partitioning of fatty acids
por: Chen, Yan Q., et al.
Publicado: (2020)

Evinacumab, an ANGPTL3 Inhibitor, in the Treatment of Dyslipidemia
por: Sosnowska, Bożena, et al.
Publicado: (2022)

The Neuroprotective Effects of Flavonoid Fisetin against Corticosterone-Induced Cell Death through Modulation of ERK, p38, and PI3K/Akt/FOXO3a-Dependent Pathways in PC12 Cells
por: Chang, Pei-Rong, et al.
Publicado: (2023)

The role of ANGPTL3 in controlling lipoprotein metabolism
por: Tikka, Anna, et al.
Publicado: (2016)

Circulating angiopoietin-like protein 8 (ANGPTL8) and ANGPTL3 concentrations in relation to anthropometric and metabolic profiles in Korean children: a prospective cohort study
por: Chung, Hye Soo, et al.
Publicado: (2016)

ANGPTL8 promotes the ability of ANGPTL3 to bind and inhibit lipoprotein lipase
por: Chi, Xun, et al.
Publicado: (2017)

Role and mechanism of the action of angiopoietin-like protein ANGPTL4 in plasma lipid metabolism
por: Kersten, Sander
Publicado: (2021)

An Integrated Computational Analysis of High-Risk SNPs in Angiopoietin-like Proteins (ANGPTL3 and ANGPTL8) Reveals Perturbed Protein Dynamics Associated with Cancer
por: Iqbal, Sajid, et al.
Publicado: (2023)

Inhibition of Angiopoietin-Like 3 (ANGPTL3) Reduces Adipose Tissue Insulin Resistance in Patients With Familial Partial Lipodystrophy
por: de Freitas, Maria Cristina Foss, et al.
Publicado: (2021)

Cord Blood Levels of Angiopoietin-Like 7 (ANGPTL7) in Preterm Infants
por: Xia, Xin, et al.
Publicado: (2020)

Impact of oral lipid and glucose tolerance tests on the postprandial concentrations of angiopoietin-like proteins (Angptl) 3 and 4
por: Schmid, Andreas, et al.
Publicado: (2021)

Angiopoietin-like 3 inhibition of endothelial lipase is not modulated by angiopoietin-like 8
por: Sylvers-Davie, Kelli L., et al.
Publicado: (2021)

The angiopoietin-like protein ANGPTL4 catalyzes unfolding of the hydrolase domain in lipoprotein lipase and the endothelial membrane protein GPIHBP1 counteracts this unfolding
por: Mysling, Simon, et al.
Publicado: (2016)

Tanshinone IIA Modulates Low Density Lipoprotein Uptake via Down-Regulation of PCSK9 Gene Expression in HepG2 Cells
por: Chen, Hung-Chen, et al.
Publicado: (2016)

MON-097 Angiopoietin-Like Protein 8 (ANGPTL8) Levels in Thai Subjects with Hyperalphalipoproteinemia
por: Kaewkrasaesin, Chatchon, et al.
Publicado: (2019)

Vaccine targeting ANGPTL3 ameliorates dyslipidemia and associated diseases in mouse models of obese dyslipidemia and familial hypercholesterolemia
por: Fukami, Hirotaka, et al.
Publicado: (2021)

Angiopoietin-like 3 (ANGPTL3) drives cell proliferation, migration and angiogenesis in cervical cancer via binding to integrin alpha v beta 3
por: Zhong, Lijun, et al.
Publicado: (2022)

Tanshinone IIA Downregulates Lipogenic Gene Expression and Attenuates Lipid Accumulation through the Modulation of LXRα/SREBP1 Pathway in HepG2 Cells
por: Gao, Wan-Yun, et al.
Publicado: (2021)

New Therapeutic Approaches to the Treatment of Dyslipidemia 1: ApoC-III and ANGPTL3
por: Kim, Ji Yoon, et al.
Publicado: (2023)

Angiopoietin-like protein 4 (ANGPTL4) is related to gestational weight gain in pregnant women with obesity
por: Ortega-Senovilla, Henar, et al.
Publicado: (2018)

Selective targeting of angiopoietin-like 3 (ANGPTL3) with vupanorsen for the treatment of patients with familial partial lipodystrophy (FPLD): results of a proof-of-concept study
por: Foss-Freitas, Maria C., et al.
Publicado: (2021)

Angiopoietin-like protein 4 (ANGPTL4) is an inhibitor of endothelial lipase (EL) while the ANGPTL4/8 complex has reduced EL-inhibitory activity
por: Chen, Yan Q., et al.
Publicado: (2021)

Structures of Angptl3 and Angptl4, modulators of triglyceride levels and coronary artery disease
por: Biterova, Ekaterina, et al.
Publicado: (2018)

Decreased Fat Storage by Lactobacillus Paracasei Is Associated with Increased Levels of Angiopoietin-Like 4 Protein (ANGPTL4)
por: Aronsson, Linda, et al.
Publicado: (2010)

Angiopoietin-like 4 (Angptl4): A glucocorticoid-dependent gatekeeper of fatty acid flux during fasting
por: Koliwad, Suneil K., et al.
Publicado: (2012)

Angiopoietin-like protein 8 (ANGPTL8)/betatrophin overexpression does not increase beta cell proliferation in mice
por: Cox, Aaron R., et al.
Publicado: (2015)

Angiopoietin-like 8 (ANGPTL8) as a potential predictor of NAFLD in paediatric patients with Prader-Willi Syndrome
por: Mele, C., et al.
Publicado: (2020)

Angiopoietin Like Protein 2 (ANGPTL2) Promotes Adipose Tissue Macrophage and T lymphocyte Accumulation and Leads to Insulin Resistance
por: Sasaki, Yusuke, et al.
Publicado: (2015)

Plasma and adipose tissue level of angiopoietin-like 7 (ANGPTL7) are increased in obesity and reduced after physical exercise
por: Abu-Farha, Mohamed, et al.
Publicado: (2017)

Circulating angiopoietin-like 8 (ANGPTL8) is a marker of liver steatosis and is negatively regulated by Prader-Willi Syndrome
por: Mele, Chiara, et al.
Publicado: (2017)

Expression of angiopoietin-like 4 fibrinogen-like domain (cANGPTL4) increases risk of brain metastases in women with breast cancer
por: Dao, Tu, et al.
Publicado: (2020)

ANGPTL4 sensitizes lipoprotein lipase to PCSK3 cleavage by catalyzing its unfolding
por: Lund Winther, Anne-Marie, et al.
Publicado: (2021)

Silencing of ANGPTL 3 (angiopoietin-like protein 3) in human hepatocytes results in decreased expression of gluconeogenic genes and reduced triacylglycerol-rich VLDL secretion upon insulin stimulation
por: Tikka, Anna, et al.
Publicado: (2014)

Angiopoietin-like proteins inhibitors: New horizons in the treatment of atherogenic dyslipidemia and familial hypercholesterolemia
por: Surma, Stanisław, et al.
Publicado: (2023)

Circulating Angptl3 and Angptl8 Are Increased in Patients with Hypothyroidism
por: Yang, Longyan, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_vkvfrvgen4rifritg2uj3pp03j